Breaking news on Cardiology
If You're Gonna Work Hard At Your Job, You'd Better Work Out Hard At The Gym Too published
Tue, 07 Sep 2010 12:00:00 PDT
Heart, published by the BMJ (British Medical Journal) has found that men that are clinically out of shape, and work longer than the conventional workday hours, more likely die of heart disease by 50% compared to males who work the same hours in a week but are in shape...
Low Carb Plant Sourced Diet Better Than Animal Sourced One published
Tue, 07 Sep 2010 07:00:00 PDT
If you want to live longer, you are better off on a low carb diet which is vegetable based, rather than one whose proteins are sourced from animals, according to a study involving 129,716 men and women published this week in the medical journal Annals of Internal Medicine...
Southampton Heart Experts Implant Europe's First 'Slinky' Stent published
Tue, 07 Sep 2010 04:00:00 PDT
Heart specialists at Southampton General Hospital are the first in Europe to implant an innovative 'slinky' coil to open a patient's blocked artery...
News From The Annals Of Internal Medicine: September 7, 2010 published
Tue, 07 Sep 2010 01:00:00 PDT
1. A Low-carb Diet Based on Animal Protein May Increase Death Risk Evidence shows that a low-carbohydrate diet produces weight loss and improves some cardiovascular risk factors. However, health effects of a low-carbohydrate diet may depend on the type of protein and fat consumed. Researchers followed 85,168 women and 44,548 men on a low-carbohydrate diet for 26 and 20 years respectively...
'Brinavess'™ (Vernakalant) For Infusion Approved In The European Union For Rapid Conversion Of Recent Onset Atrial Fibrillation published
Tue, 07 Sep 2010 00:00:00 PDT
MSD (known in the and as Merck) (NYSE:MRK) and Cardiome Pharma Corp. (NASDAQ: CRME/ TSX: COM) announced that the intravenous (IV) formulation of 'Brinavess'™ (vernakalant) has been granted marketing approval in the European Union (EU), and for the conversion of recent onset atrial fibrillation (AF) to sinus rhythm in adults...
Using SYNTAX Scoring To Indicate The Outcomes From CABG And PCI Procedures In Multivessel Coronary Disease published
Tue, 07 Sep 2010 00:00:00 PDT
There have been several studies into the impact of completeness of revascularisation in recent years, yet few clear recommendations are available on the likely clinical outcomes. This topic is not formally addressed in either the European Society of Cardiology guidelines or those jointly issued by the American Heart Association and American College of Cardiology...
International Study Led By VA-Harvard Physician Yields Insight On Risks From Fatty Arteries published
Mon, 06 Sep 2010 05:00:00 PDT
An international study of clinical data led by a Department of Veterans Affairs (VA)-Harvard University cardiologist found that patients with deposits of fatty plaque in their arteries are at especially high risk for life-threatening cardiovascular events if they have diabetes, disease in multiple arteries or a history of heart attack or stroke...
'Jailbreak' Bacteria Can Trigger Heart Disease published
Mon, 06 Sep 2010 02:00:00 PDT
Plaque-causing bacteria can jailbreak from the mouth into the bloodstream and increase your risk of heart attack says a scientist at the Society for General Microbiology's autumn meeting in Nottingham. Professor Howard Jenkinson, from the University of Bristol explains how oral bacteria can wreak havoc if they are not kept in check by regular brushing and flossing...
$11.6 Million To Study Cardiac Proteins published
Mon, 06 Sep 2010 01:00:00 PDT
A blood test to diagnose which heart attack survivors will suffer heart failure is the goal of a new five-year, $11.6 million contract to the UT Health Science Center San Antonio from the National Heart, Lung, and Blood Institute (NHLBI). Each year more than 1.2 million Americans suffer a heart attack...
Molecules Involved In Touch And Other Mechanically Activated Systems Identified published
Mon, 06 Sep 2010 00:00:00 PDT
Scripps Research Institute scientists have identified two proteins with potential to be important targets for research into a wide range of health problems, including pain, deafness, and cardiac and kidney dysfunction. The study was published in Science Express, the advanced, online edition of the journal Science...
How Bone-Marrow Stem Cells Hold Their 'Breath' In Low-Oxygen Environments published
Mon, 06 Sep 2010 00:00:00 PDT
UT Southwestern Medical Center researchers have identified unique metabolic properties that allow a specific type of stem cell in the body to survive and replicate in low-oxygen environments...
Link Between Chronic Stress And Heart Attack: Hair Provides Proof published
Mon, 06 Sep 2010 00:00:00 PDT
Researchers at The University of Western Ontario have provided the first direct evidence using a biological marker, to show chronic stress plays an important role in heart attacks. Stressors such as job, marital and financial problems have been linked to the increased risk for developing cardiovascular disease including heart attack...
Value Of Oxygen Therapy In End-Of-Life Care Challenged By Study published
Sat, 04 Sep 2010 00:00:00 PDT
Millions of patients with advanced disease in palliative care settings receive oxygen therapy to help them breathe more easily. But a new study from Duke University Medical Center says roughly half of them don't benefit from the intervention, and among those who do benefit, it doesn't make a bit of difference whether they get pure oxygen or just plain old room air - both offer equal benefit...
Cortisol Levels In Hair Linked To Heart Attack Risk published
Sat, 04 Sep 2010 00:00:00 PDT
Cortisol levels in hair may be the first biomarker to measure chronic (long-term) stress, which is linked to a higher risk of having a heart attack (acute myocardial infarction), according to a new study published in the medical journal Stress...
Cardiogenesis Comments On The STAR-Heart Study Presented At European Society Of Cardiology (ESC) 2010 Congress published
Fri, 03 Sep 2010 04:00:00 PDT
Cardiogenesis Corporation (OTCQB: CGCP), released comments regarding the STAR-heart study...
Long Term Data Presented At ESC 2010 Further Support The Benefit Of The CYPHER(R) Sirolimus Drug-Eluting Stent published
Fri, 03 Sep 2010 03:00:00 PDT
Three new analyses of subgroups from the SORT OUT III study presented at the European Society of Cardiology (ESC) meeting in Stockholm, Sweden, provide additional detail on longer-term follow-up subgroup safety and efficacy outcomes in the SORT OUT III trial in three high-risk subgroups (diabetes, acute coronary syndrome and multiple lesion)...
Double-Dose Clopidogrel Reduces Risk Of Death, Heart Attack Or Stroke In Patients Undergoing Angioplasty published
Fri, 03 Sep 2010 03:00:00 PDT
A double-dose of the anti-clotting treatment clopidogrel, also known as Plavix, significantly reduces complications in heart patients undergoing angioplasty to clear blocked arteries. Shamir R. Mehta, an interventional cardiologist and associate professor of medicine of the Michael G...
BRINAVESS™ (vernakalant) For Infusion Approved In The European Union For Rapid Conversion Of Recent Onset Atrial Fibrillation published
Fri, 03 Sep 2010 02:00:00 PDT
MSD (known in the US and Canada as Merck) (NYSE:MRK) and Cardiome Pharma Corp. (NASDAQ: CRME/ TSX: COM) announced that the intravenous (IV) formulation of BRINAVESS™ (vernakalant) has been granted marketing approval in the European Union (EU), Iceland and Norway for the conversion of recent onset atrial fibrillation (AF) to sinus rhythm in adults...
New Online Health Test Helps Hispanics Cut Risk Of Heart Disease, Stroke published
Fri, 03 Sep 2010 00:00:00 PDT
As families return to the frenzied back-to-school pace, the American Heart Association is urging Hispanics to make time for the most important test they can take: a simple online health assessment to help them avoid heart disease and stroke...
BRINAVESS™ (vernakalant) For Infusion Approved In The European Union For Rapid Conversion Of Recent Onset Atrial Fibrillation published
Thu, 02 Sep 2010 04:00:00 PDT
Merck (known as MSD outside the United States and Canada) (NYSE:MRK) and Cardiome Pharma Corp...
InfraReDx Receives FDA Clearance For LipiScan™ IVUS Coronary Imaging System published
Thu, 02 Sep 2010 02:00:00 PDT
InfraReDx, Inc., a medical device company developing intelligent cardiovascular diagnostic imaging technologies, announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market the LipiScan™ IVUS Coronary Imaging System...
Experts Wonder Why Slimming Drug Meridia (sibutramine) Is Still On The Market In USA published
Thu, 02 Sep 2010 01:00:00 PDT
Sibutramine, brand name Meridia is an appetite suppressant, a weight loss pill. Editors at the NEJM (New England Journal of Medicine) write it is difficult for them to discern a "credible rationale for keeping this medication on the market", even though it is restricted for people without heart disease...
New 2010 ESC Guidelines For Percutaneous Coronary Interventions Reinforce Importance Of FFR In Treatment Of Coronary Artery Disease published
Wed, 01 Sep 2010 06:00:00 PDT
St. Jude Medical, Inc. (NYSE:STJ) applauds the updated class and level of evidence for Fractional Flow Reserve (FFR)-guided treatment in the Guidelines on Percutaneous Coronary Intervention (PCI) announced Monday at the European Society of Cardiology (ESC) congress in Stockholm...
Rivaroxaban Successfully Demonstrated Non-Inferiority Compared To Standard Of Care For The Prevention Of VTE In Pivotal Phase 3 Study published
Wed, 01 Sep 2010 05:00:00 PDT
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), announced that the investigational, oral anticoagulant rivaroxaban successfully demonstrated non-inferiority compared to the standard of care1 for the prevention of recurrent venous thromboembolism (VTE) in patients with acute symptomatic deep vein thrombosis (DVT), with a comparable safety profile...
Potential For New Antihypertensives From Study Of System For Eliminating Salt published
Wed, 01 Sep 2010 05:00:00 PDT
A study of the body system that deals with Americans' love affair with salt may yield more insight into why so many end up hypertensive and how to better treat them. A team of scientists from the Medical College of Georgia, the University of Utah and the University of Texas at San Antonio is looking at how the kidneys know you've eaten too much salt and what they do to eliminate it...
)
|
|
